Genomate
Precision Medicine · Artificial Intelligence
$10.4Mtotal raised · 3 rounds on record
$2Mlatest round · Convertible Note · Mar 2025 · 20 mo ago
50+team · employees, estimated range
2022founded
Overview
Genomate helps physicians find the right targeted therapy for every cancer patient based on the individual molecular profile of their tumor. AI-powered precision oncology. The right drug. The first time. Every time.
Funding and backers
Total raised
$10.4M
3 rounds on record
Latest round
$2M
Convertible Note · Mar 2025 · 20 mo ago
Team
51-200
employees, estimated range
The money's age
Due for its next round
20 months since the last round · not hiring
Momentum
15/100
in the news
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
May 5, 2025
New executive Genomate Health Appoints CEO to Lead Commercial Expansion · newswire.com
Mar 5, 2025
Raised a round Convertible Note $2M · SEC Form D
Oct 10, 2023
Raised a round Convertible Note $2.7M · SEC Form D
Oct 28, 2022
Raised a round Convertible Note $5.7M · SEC Form D
2022
Founded
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Convertible Note | Mar 2025 | $2M | — | SEC Form D |
| Convertible Note | Oct 2023 | $2.7M | — | SEC Form D |
| Convertible Note | Oct 2022 | $5.7M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | GENOMATE HEALTH, INC. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Istvan PetakExecutive Officer, DirectorSEC Form D
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Precision oncology, built for Latin America. Point-of-care software and a multimodal cancer atlas.
Medicus (MedicusAI) develops AI-powered digital pathology and precision oncology solutions for hospitals, labs, and pharma partners.
RNA intelligence for precision oncology. Blank Bio builds AI foundation models that help pharma teams identify the right patients for…
StratifAI is a precision oncology company developing the next generation of biomarkers to advance cancer diagnostics.
Genialis is a precision oncology company helping the most promising molecules become life-saving medicines.
Solid IO is transforming precision oncology with organ-on-chip technology, delivering real-time, patient-specific insights to improve…
People
Istvan Petak
Executive Officer, Director
Richard Schwab
Director
Jared Schrieber
Director
Scott Friedman
Director
Laszlo Mechtler
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
News
Genomate and VivaMed to Rescue and Repurpose Oncology Drugs with AI and Clinical Data
The collaboration aims to identify and advance new oncology drug candidates.CAMBRIDGE, MA / ACCESS Newswire / October 27, 2026 / , a precision oncology company, today announced a strategic partnership with VivaMed BioPharma to advance existing drugs and p
Read more
Report
Genomate Health: Genomate and VivaMed to Rescue and Repurpose Oncology Drugs with AI and Clinical Data
The collaboration aims to identify and advance new oncology drug candidates. CAMBRIDGE, MA / ACCESS Newswire / October 27, 2026 / Genomate Health, a precision oncology company, today announced a strategic
Read more
Report
Report
Report
Genomate Health Second Opinion Service
Genomate Health has launched its physician-led, AI-powered second opinion service, available via telehealth and eligible for HSA/FSA reimbursement. Genomate's AI builds a personalized model of each patient's solid tumor, informing medical experts of optim
Read more
Report
Genomate Health: Many Cancer Patients Leave Treatment Options on the Table - You Don't Have To
Thousands of cancer patients have untapped treatment options in their genomic data. Now they can find them. Available in 12 states, expanding nationwide. CAMBRIDGE, MA / ACCESS Newswire / June 10, 2026
Read more
Report
Genomate Health Expands Global Footprint With Acquisition of Oncompass Medicine
Genomate Health, the U.S.-based precision medicine company transforming cancer care through its proprietary computational reasoning technology, today announced its acquisition of Oncompass Medicine. The move marks a major milestone in Genomate Health
Read more
Report
Genomate Health Expands Global Footprint With Acquisition of Oncompass Medicine
Genomate Health, the U.S.-based precision medicine company transforming cancer care through its proprietary computational reasoning technology, today announced its acquisition of Oncompass Medicine. The move marks a major milestone in Genomate Health
Read more
Report
Genomate Health Expands Global Footprint With Acquisition of Oncompass Medicine
Genomate Health, the U.S.-based precision medicine company transforming cancer care through its proprietary computational reasoning technology, today announced its acquisition of Oncompass Medicine. The
Read more
Report
The Case for Computational Reasoning in Precision Oncology
By: Alina Luchian and Dr. Istvan Petak, Founder and CSO - Genomate Precision oncology has long promised to revolutionize cancer treatment by tailoring therapies to each tumor's unique genetic profile. …
Read more
Report
Show more news
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Cambridge
United States
HQ
50-200 est. staff